Six Months FY3/2026 Earnings Report

October 31, 2025

Company name: PEGASUS CO., LTD. Listing: Tokyo Stock Exchange Securities code: 6262

URL: https://www.pegasus.co.jp

Representative: Shigemi Mima Representative Director

Inquiries: Masakazu Tada Executive Officer Telephone: +81-6(6451)1351

Scheduled date to file semi-annual securities report: November 11, 2025 Scheduled date to commence dividend payments: November 28, 2025 Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)
   1. Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)

      	Net sales		Operating profit		Ordinary profit		Profit attributable to owners of parent
      Six months ended September 30, 2025 September 30, 2024	Millions of yen 11,409 10,467	% 9.0 18.6	Millions of yen 669 784	% (14.6) 548.7	Millions of yen 662 567	% 16.7 (14.8)	Millions of yen 414 237	% 74.4 (45.9)

      Note: Comprehensive income	For the six months ended September 30, 2025:	¥	(1,587) million [	-%]
      	For the six months ended September 30, 2024:	¥	3,329 million [	25.8%]

      	Basic earnings per share	Diluted earnings per share
      Six months ended	Yen	Yen
      September 30, 2025	16.70	-
      September 30, 2024	9.58	-

   2. Consolidated financial position

   	Total assets	Net assets	Equity-to-asset ratio
   As of September 30, 2025 March 31, 2025	Millions of yen 43,943 46,391	Millions of yen 31,740 33,637	% 69.9 70.0

   Reference: Equity

   As of September 30, 2025:	¥	30,710 million
   As of March 31, 2025:	¥	32,477 million

2. Cash dividends

   	Annual dividends per share
   	First quarter-end	Second quarter-end	Third quarter-end	Fiscal year-end	Total
   	Yen	Yen	Yen	Yen	Yen
   Fiscal year ended March 31, 2025	-	5.00	-	8.00	13.00
   Fiscal year ending March 31, 2026	-	10.00
   Fiscal year ending March 31, 2026 (Forecast)			-	-	-

   (Note) 1 Revision to the forecast for dividends announced most recently: None

   2 The year-end dividend forecast for the fiscal year ending March 31, 2026 is undecided because it is difficult to forecast at this time.

3. Consolidated financial result forecasts for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)

(Percentages indicate year-on-year changes.)

(Note) 1 Revision to the financial results forecast announced most recently: None

2 The consolidated earnings forecast does not currently reflect the potential impact of U.S. tariff policy.

1. Adoption of accounting treatment specific to the preparation of semi-annual consolidated financial statements: None

2. Changes in accounting policies, changes in accounting estimates, and restatement

   1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

   2. Changes in accounting policies due to other reasons: None

   3. Changes in accounting estimates: None

   4. Restatement: None

3. Number of issued shares (common shares)

   1. Total number of issued shares at the end of the period (including treasury shares)

      As of September 30, 2025	24,828,600 shares
      As of March 31, 2025	24,828,600 shares

   2. Number of treasury shares at the end of the period

      As of September 30, 2025	17,976 shares
      As of March 31, 2025	17,976 shares

   3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

(Note) 1 Semi-annual financial results reports are exempt from review conducted by certified public accountants or an audit firm.

2 Proper use of earnings forecasts, and other special matters

Statements contained in this summary regarding the Company's plans, strategies, and expectations for future performance, which are based on information available to the Company at the time of writing.

They are therefore subject to a number of uncertainties and unknowable factors, and actual results may thus differ substantially from those projected.

Semi-annual Consolidated Financial Statements and Primary Notes Semi-annual Consolidated Balance Sheet

(Thousands of yen)

As of March 31, 2025

As of September 30, 2025

Assets

Valuation difference on available-for-sale securities

(190,550)

(163,364)

As of March 31, 2025

As of September 30, 2025

Accumulated other comprehensive income

Foreign currency translation adjustment

8,314,959

6,323,828

Total accumulated other comprehensive income

8,363,571

6,380,861

Total net assets

33,637,431

31,740,254

Total liabilities and net assets 46,391,590 43,943,088

Non-controlling interests 1,159,906 1,029,520

Remeasurements of defined benefit plans 239,161 220,396

(Thousands of yen)

Semi-annual Consolidated Statements of Income and Comprehensive Income